COVASCERT Trademark

Trademark Overview

On Friday, May 3, 2019, a trademark application was filed for COVASCERT with the United States Patent and Trademark Office. The USPTO has given the COVASCERT trademark a serial number of 88414150. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 11, 2021. This trademark is owned by Amgen Inc.. The COVASCERT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of cancer, tumorous diseases, autoimmune diseases, inflammation, inflammatory diseases and disorders, neurologic diseases and disorders, metabolic diseases and disorders, and cardiovascular diseases and disorders
covascert

General Information

Serial Number88414150
Word MarkCOVASCERT
Filing DateFriday, May 3, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 11, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 16, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of cancer, tumorous diseases, autoimmune diseases, inflammation, inflammatory diseases and disorders, neurologic diseases and disorders, metabolic diseases and disorders, and cardiovascular diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, May 19, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Tuesday, October 12, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 11, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, April 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 23, 2021EXTENSION 3 GRANTED
Wednesday, March 10, 2021EXTENSION 3 FILED
Wednesday, April 21, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 17, 2021NOTICE OF REVIVAL - E-MAILED
Wednesday, March 17, 2021EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, March 17, 2021PETITION TO REVIVE-GRANTED
Wednesday, March 17, 2021TEAS PETITION TO REVIVE RECEIVED
Wednesday, September 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 31, 2020EXTENSION 2 GRANTED
Monday, August 31, 2020EXTENSION 2 FILED
Monday, August 31, 2020TEAS EXTENSION RECEIVED
Saturday, February 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 27, 2020EXTENSION 1 GRANTED
Thursday, February 27, 2020EXTENSION 1 FILED
Thursday, February 27, 2020TEAS EXTENSION RECEIVED
Tuesday, September 10, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 16, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 26, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 7, 2019ASSIGNED TO LIE
Friday, May 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 24, 2019EXAMINER'S AMENDMENT ENTERED
Friday, May 24, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 24, 2019EXAMINERS AMENDMENT E-MAILED
Friday, May 24, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 22, 2019ASSIGNED TO EXAMINER
Sunday, May 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 7, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

covascert diseases disorders inflammatory neurologic cardiovascular metabolic inflammation autoimmune preparations treatment